Advances in Genetic Diagnostics (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service provides an assessment of key component technology areas within the genetic testing space, and offers insights and recommendations for managing the R&D portfolio effectively. Incorporated analysis includes a strategic evaluation of R&D portfolio within this space using a multicriteria decision making tool, an assessment of research orientation among key focus areas in the industry, analysis of the challenging environment for R&D, and an overview of emerging market needs. Finally, a discussion of future R&D trends and insights on strategically managing the R&D pipeline is also included.

Table of Contents

Advances in Genetic Diagnostics (Technical Insights), Executive SummaryResearch OverviewUnderstanding Genetic DisordersTesting Genes for Different ReasonsScope and MethodologyResearch Scope and SegmentationMethodologyAdvances in Genetic Diagnostics (Technical Insights), Strategic Assessment of the Industry EnvironmentR&D Portfolio AnalysisResearch PortfolioResearch OrientationR&D Funding PatternEnvironmental AnalysisKey Technical Challenges Key Business ChallengesAdvances in Genetic Diagnostics (Technical Insights), Industry Best Practices and Strategic InsightsAssessment of Networks and PartnershipsNetworks for Research and Better DataR&D Focus AreasAssessment of Strategic AlliancesStrategic Evaluation of the R&D PortfolioSneak Preview of the AHP TreeAdvances in Genetic Diagnostics (Technical Insights), Patents; Contacts; Glossary; and AppendixPatent Report and ContactsPatents Landscape Report on Genetic TestingKey ContactsAppendices and GlossaryAppendix A1--Analytical Hierarchy ProcessGlossary of AbbreviationsAdvances in Genetic Diagnostics (Technical Insights), Decision Support TablesDSD TablesNumber of Biotech Companies (Million USD)--World (2004 to 2014)Government Investment in Biotech R&D (Million USD)--World (2004 to 2014)Total Healthcare Expenditure (Billion USD)--World (2004 to 2014)




Related Research

Release Date : 08-Sep-17

Region : Global

Release Date : 08-Sep-17

Region : Global

Release Date : 01-Sep-17

Region : Global

Release Date : 25-Aug-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.